Xofigo

What Xofigo Means in Everyday Medical Language

Xofigo is a medicine that contains a radioactive substance called radium Ra 223. It is used to treat prostate cancer that has spread to the bones and no longer responds to treatments that lower testosterone, known as castration-resistant prostate cancer. The drug works by traveling through the bloodstream and collecting in areas of the bone where cancer has spread. Once there, it releases radiation that may help kill cancer cells and reduce symptoms caused by bone metastases. Because it targets bone tissue specifically, it helps focus treatment on cancer in the bones while limiting effects on other parts of the body.

Why Xofigo Can Matter in Cancer Care

For men with prostate cancer that has stopped responding to hormone treatments, options can be limited, especially when the cancer spreads to the bones and causes pain or other symptoms. Xofigo offers a targeted treatment that delivers radiation directly to bone metastases. This can help manage symptoms, improve quality of life, and may extend survival. It is important to know that Xofigo is used only when cancer has spread to the bones but not to other organs. This focused approach helps reduce damage to healthy tissues compared to other types of radiation therapy.

What Patients Might See or Hear About Xofigo

Patients may hear the name Xofigo or radium Ra 223-dichloride during conversations about treatment options for advanced prostate cancer. It might appear in medical reports, treatment plans, or when doctors discuss radiopharmaceutical therapies—treatments that use radioactive substances to target cancer. Because it is a specialized drug, patients might also find information about it when looking into clinical trials or new research studies. Understanding that Xofigo is a form of radiation therapy given through an injection can help patients prepare for what to expect.

Common Confusions and Clarifications

Xofigo is sometimes called radium Ra 223-dichloride, so seeing different names for the same drug can be confusing. It is not a hormone therapy but a type of radiation treatment delivered through the bloodstream. Also, this treatment is specifically for prostate cancer that has spread to bones and is castration resistant; it is not used for cancers that have spread to other organs or for earlier stages of prostate cancer. Knowing these details can help avoid misunderstandings about when and how Xofigo is used.

Practical Questions to Ask Your Care Team

If Xofigo is mentioned as a treatment option, you might ask how it works, what side effects to expect, and how it fits with other treatments you are receiving. It is also helpful to ask if your cancer has spread only to bones or other organs, as this affects whether this drug is appropriate. Discussing the goals of treatment and how it may affect symptoms and quality of life can guide your decisions. Your healthcare team can provide personalized information about what to expect before, during, and after treatment.

Understanding the Context and Next Steps

This information is meant to help you understand what Xofigo is and how it may be used in prostate cancer care. It is not a substitute for personalized medical advice. If you see this term in your medical records or hear it from your doctor, the best next step is to ask your healthcare team to explain what it means for your specific situation. They can provide details about whether this treatment is suitable and what to expect. Learning about clinical trials or new research may also be helpful if you are interested in exploring additional options.

Safety and Educational Note

This entry is for educational purposes and does not decide what is safe, appropriate, or effective for any individual patient. Treatment decisions depend on many factors unique to each person. Always discuss your care with your healthcare team before starting or changing treatments.